What are the molecular mechanisms for the antiproliferative effects of nitric oxide and cGMP in vascular smooth muscle?
Murad
F
F
D000470:Alkaloids / Q000494:pharmacology; D000818:Animals; D002227:Carbazoles; D002455:Cell Division; D006152:Cyclic GMP / Q000031:analogs & derivatives / Q000494:pharmacology / Q000502:physiology*; D004791:Enzyme Inhibitors; D006801:Humans; D007211:Indoles; D009131:Muscle, Smooth, Vascular / Q000737:chemistry* / Q000187:drug effects / Q000502:physiology*; D009569:Nitric Oxide / Q000502:physiology*; D009599:Nitroprusside / Q000494:pharmacology; D047428:Protein Kinase Inhibitors; D051381:Rats; D015290:Second Messenger Systems
D000470:Alkaloids; D002227:Carbazoles; D004791:Enzyme Inhibitors; D007211:Indoles; D047428:Protein Kinase Inhibitors; C073601:KT 5823; D009599:Nitroprusside; C016276:8-bromocyclic GMP; D009569:Nitric Oxide; D006152:Cyclic GMP